Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3Phase 2/3 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 161NIH 35NETWORK 10OTHER_GOV 3INDUSTRY 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Turcot syndrome 1Ovarian Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1

Interventions

Capecitabine 28apatinib 25Oxaliplatin 24Cisplatin 24tislelizumab 23Gemcitabine 23Irinotecan 19Paclitaxel 18Carboplatin 18Docetaxel 15Bevacizumab 15Fluorouracil 14Drug Therapy 13Cyclophosphamide 11pembrolizumab 10camrelizumab 10Vinorelbine 9Radiation 9S 1 (combination) 8Leucovorin 8Cetuximab 8toripalimab 7sintilimab 7Rituximab 7Erlotinib Hydrochloride 7pyrotinib 6Gefitinib 6Albumin-Bound Paclitaxel 6fludarabine 5anlotinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Neoadjuvant Therapy × Clear all
NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
220 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05913570 2023-06-22

MSI-H/dMMR

Henan Cancer Hospital

Phase 2 Unknown
22 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT00620269 2011-11-07

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

National Cancer Center, Korea

Phase 2 Unknown
212 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡